Literature DB >> 17917076

A genetic variant in cytoskeleton motors amplifies susceptibility to leukoaraiosis in hypertensive smokers: gene-environmental interactions behind vascular white matter demyelinization.

Zoltan Szolnoki1, Andras Kondacs, Yvette Mandi, Ferenc Somogyvari.   

Abstract

One of the most frequent causes of an age-associated cognitive decline is the vascular white matter demyelinization of the brain referred to as leukoaraiosis (LA). The wide range of severity of the cognitive decline caused by LA can have numerous deleterious effects on the quality of life, leading overall to far-reaching public health problems. Besides clinical risk factors such as hypertension and advanced age, genetic susceptibility factors are presumed to be of great importance in the development of LA. The protein kinesin, which is the main motor protein in the trafficking system of the mitochondria, can undergo functional damage under the circumstances of chronic hypoxia. This may give rise to a slowly developing metabolic crisis in the glia cells, a phenomenon hypothesized to account for the evolution of LA. Setting out from this assumption, we examined how the kinesin light-chain 1 (KNS2) G56836C single nucleotide polymorphism in intron 13 affects the susceptibility to LA. This genetic variant was found to be associated with cognitive disturbances and neurodegeneration, and it was presumed to affect the function of kinesin. The association analysis of the above genetic variant was performed in 229 patients with LA and 264 neuroimaging alteration-free controls. The KNS2 56836CC variant increased the risk of LA 7.76-fold in hypertensive smokers as compared with those not carrying this variant. This finding may be useful in everyday clinical practice by indicating the need for stricter preventive measures in CC carriers.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17917076     DOI: 10.1007/s12031-007-0062-z

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  38 in total

Review 1.  Pathophysiology of age-related cerebral white matter changes.

Authors:  Leonardo Pantoni
Journal:  Cerebrovasc Dis       Date:  2002       Impact factor: 2.762

2.  Leuko-araiosis: an ancient term for a new problem.

Authors:  V C Hachinski; P Potter; H Merskey
Journal:  Can J Neurol Sci       Date:  1986-11       Impact factor: 2.104

3.  Apolipoprotein E polymorphism and silent microangiopathy-related cerebral damage. Results of the Austrian Stroke Prevention Study.

Authors:  R Schmidt; H Schmidt; F Fazekas; M Schumacher; K Niederkorn; P Kapeller; V Weinrauch; G M Kostner
Journal:  Stroke       Date:  1997-05       Impact factor: 7.914

4.  Cerebral white matter lesions are not associated with apoE genotype but with age and female sex in Alzheimer's disease.

Authors:  H Sawada; F Udaka; Y Izumi; K Nishinaka; H Kawakami; S Nakamura; M Kameyama
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-05       Impact factor: 10.154

5.  Markers of endothelial dysfunction in lacunar infarction and ischaemic leukoaraiosis.

Authors:  Ahamad Hassan; Beverley J Hunt; Michael O'Sullivan; Kiran Parmar; John M Bamford; Dennis Briley; Martin M Brown; Dafydd J Thomas; Hugh S Markus
Journal:  Brain       Date:  2003-02       Impact factor: 13.501

6.  Age, hypertension, and lacunar stroke are the major determinants of the severity of age-related white matter changes. The LADIS (Leukoaraiosis and Disability in the Elderly) Study.

Authors:  Anna Maria Basile; Leonardo Pantoni; Giovanni Pracucci; Kjell Asplund; Hugues Chabriat; Timo Erkinjuntti; Franz Fazekas; José M Ferro; Michael Hennerici; John O'Brien; Philip Scheltens; Marieke C Visser; Lars-Olof Wahlund; Gunhild Waldemar; Anders Wallin; Domenico Inzitari
Journal:  Cerebrovasc Dis       Date:  2006-02-14       Impact factor: 2.762

7.  MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging.

Authors:  F Fazekas; J B Chawluk; A Alavi; H I Hurtig; R A Zimmerman
Journal:  AJR Am J Roentgenol       Date:  1987-08       Impact factor: 3.959

Review 8.  Leukoaraiosis and vascular dementia.

Authors:  J van Gijn
Journal:  Neurology       Date:  1998-09       Impact factor: 9.910

9.  Are genetic factors important in the aetiology of leukoaraiosis? Results from a memory clinic population.

Authors:  K Amar; S MacGowan; G Wilcock; T Lewis; M Scott
Journal:  Int J Geriatr Psychiatry       Date:  1998-09       Impact factor: 3.485

Review 10.  Ischemic delayed neuronal death. A mitochondrial hypothesis.

Authors:  K Abe; M Aoki; J Kawagoe; T Yoshida; A Hattori; K Kogure; Y Itoyama
Journal:  Stroke       Date:  1995-08       Impact factor: 7.914

View more
  4 in total

1.  A cytoskeleton motor protein genetic variant may exert a protective effect on the occurrence of multiple sclerosis: the janus face of the kinesin light-chain 1 56836CC genetic variant.

Authors:  Zoltan Szolnoki; Andras Kondacs; Yvette Mandi; Ferenc Somogyvari
Journal:  Neuromolecular Med       Date:  2007-10-13       Impact factor: 3.843

2.  A homozygous genetic variant of mitochondrial uncoupling protein 4 exerts protection against the occurrence of multiple sclerosis.

Authors:  Zoltan Szolnoki; Andras Kondacs; Yvette Mandi; Anita Bodor; Ferenc Somogyvari
Journal:  Neuromolecular Med       Date:  2009-06-18       Impact factor: 3.843

3.  Kinesin light chain 1 gene haplotypes in three conformational diseases.

Authors:  Malin von Otter; Sara Landgren; Staffan Nilsson; Caroline Lundvall; Lennart Minthon; Nenad Bogdanovic; Niels Andreasen; Deborah R Gustafson; Ingmar Skoog; Anders Wallin; Anna Håkansson; Hans Nissbrandt; Madeleine Zetterberg; Gunnar Tasa; Kaj Blennow; Henrik Zetterberg
Journal:  Neuromolecular Med       Date:  2009-11-13       Impact factor: 3.843

4.  Characteristic imprint of single nucleotide polymorphisms in multiple sclerosis.

Authors:  Zoltan Szolnoki; Andras Kondacs; Yvette Mandi; Ferenc Somogyvari
Journal:  J Mol Neurosci       Date:  2008-08-22       Impact factor: 3.444

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.